Vicki Sato
Chairman bij DENALI THERAPEUTICS INC.
Vermogen: 18 M $ op 29-02-2024
Profiel
Dr. Vicki L. Sato is onafhankelijk bestuurder bij Akouos, Inc., niet-uitvoerend voorzitter bij Vir Biotechnology, Inc., niet-uitvoerend voorzitter bij Denali Therapeutics, Inc., Lead Independent Director bij Bristol Myers Squibb Co., lid van de raad van bestuur van The Isabella Stewart Gardner Museum, Inc. en Venture Partner bij ARCH Venture Partners LLC. Zij zit in de Raad van Bestuur van Akouos, Inc., Bristol Myers Squibb Co., Peer Health Exchange en Prize4Life, Inc. Dr. Sato was voorheen werkzaam als Onafhankelijk Bestuurder bij BorgWarner, Inc., Onafhankelijk Bestuurder bij Syros Pharmaceuticals, Inc., Onafhankelijk Niet-Uitvoerend Bestuurder bij Galapagos NV, hoogleraar aan de Harvard Business School, hoogleraar aan de Harvard University, Onafhankelijk Bestuurder bij PerkinElmer, Inc. (Verenigde Staten), President bij Vertex Pharmaceuticals, Inc., Vice President-Research bij Biogen Idec, Inc., Bedrijfsadviseur bij Atlas Venture, Inc., Adviseur bij BioVentures Investors, Trustee bij het Jos Mateo Ballet Theater, en Lid van de Raad van Wetenschappelijke Adviseurs bij The Broad Institute, Inc. Zij was ook lid van de raad van bestuur van Proclara Biosciences, Inc., Alnylam Pharmaceuticals, Inc., Avila Therapeutics, Inc., Infinity Pharmaceuticals, Inc. en Nimbus Therapeutics LLC. Zij behaalde haar doctorale graad aan de Harvard University, een doctorale graad aan het Radcliffe College en een doctorale graad aan de Harvard University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0.97% | 30-06-2023 | 1 315 351 ( 0.97% ) | 15 M $ | 29-02-2024 |
DENALI THERAPEUTICS INC.
0.09% | 15-03-2024 | 119 709 ( 0.09% ) | 2 M $ | 29-02-2024 |
13-06-2023 | 101 100 ( 0.06% ) | 496 401 $ | 29-02-2024 |
Actieve functies van Vicki Sato
Bedrijven | Functie | Begin |
---|---|---|
DENALI THERAPEUTICS INC. | Chairman | 01-08-2016 |
VIR BIOTECHNOLOGY, INC. | Chairman | 01-12-2016 |
ALLOGENE THERAPEUTICS, INC. | Director/Board Member | 30-07-2021 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Analyst | - |
Peer Health Exchange
Peer Health Exchange Miscellaneous Commercial ServicesCommercial Services Peer Health Exchange is an organization that creates education opportunities for peers to share tools and resources with young people to make healthy decisions. The non-profit company is based in San Francisco, CA. Peer Health Exchange's mission is to build healthier communities with young people and advance health equity and improve health outcomes for young people in under-resourced communities. The company also offers donation matching to improve youth health and wellness. The company was founded by Louise Langheier and Angela Glymph has been the CEO of the company since 2014. | Director/Board Member | - |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Director/Board Member | - |
The Isabella Stewart Gardner Museum, Inc.
The Isabella Stewart Gardner Museum, Inc. Other Consumer ServicesConsumer Services The Isabella Stewart Gardner Museum, Inc. is a non-profit company based in Boston, MA. | Corporate Officer/Principal | - |
PerkinElmer, Inc.
PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Director/Board Member | - |
Eerdere bekende functies van Vicki Sato
Bedrijven | Functie | Einde |
---|---|---|
AKOUOS | Director/Board Member | 01-12-2022 |
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Vicki Sato
Harvard University | Doctorate Degree |
Radcliffe College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 12 |
---|---|
BORGWARNER INC. | Producer Manufacturing |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
BIOGEN INC. | Health Technology |
REVVITY, INC. | Health Technology |
GALAPAGOS NV | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
DENALI THERAPEUTICS INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 13 |
---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Finance |
José Mateo Ballet Theatre | |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
The Isabella Stewart Gardner Museum, Inc.
The Isabella Stewart Gardner Museum, Inc. Other Consumer ServicesConsumer Services The Isabella Stewart Gardner Museum, Inc. is a non-profit company based in Boston, MA. | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Commercial Services |
PerkinElmer, Inc.
PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Commercial Services |
Peer Health Exchange
Peer Health Exchange Miscellaneous Commercial ServicesCommercial Services Peer Health Exchange is an organization that creates education opportunities for peers to share tools and resources with young people to make healthy decisions. The non-profit company is based in San Francisco, CA. Peer Health Exchange's mission is to build healthier communities with young people and advance health equity and improve health outcomes for young people in under-resourced communities. The company also offers donation matching to improve youth health and wellness. The company was founded by Louise Langheier and Angela Glymph has been the CEO of the company since 2014. | Commercial Services |
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |